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Introduction
Primary squamous cell carcinoma of the thyroid 
(PSCCT) is a highly malignant neoplasm with a poor pro-
gnosis, with a median survival of 9-12 months and a median 
survival rate of 20% (1,2). It’s a rare tumor and represents 
1% of malignant thyroid neoplasms and presents a clini-
Abstract  
Primary squamous cell carcinoma of the thyroid (PSCCT) is a rare 
malignant disease with rapid fatal prognosis. The onset is generally 
characterized by sudden bilateral latero-cervical lymphadenopathy. 
The Authors report patient of 58-year-old who referred for evaluation 
of rapidly aggravating bilateral latero-cervical lymphadenopathy. The 
US highlighted the presence of a hypoechoic nodular lesion characte-
rized by peri and intra-nodular vascularization. Multilayer CT showed 
diffused involvement of mediastinal and bilateral latero-cervical lymph 
nodes, with no evidence of primary pulmonary neoplasia or elsewhere. 
The patient underwent total thyroidectomy. The peri-isthmic tissue was 
removed due to the presence of a small roundish formation, that was 
due to lymph node metastasis at histological examination.  Histological 
diagnosis: PSCCT. The immunohistochemical panel of the thyroid 
lesion was indispensable for the differential diagnosis between PSCCT, 
medullary carcinoma, anaplastic carcinoma, and thyroid metastasis of 
neoplasia with unknown primitiveness. The patient underwent che-
motherapeutic treatment with Carboplatin and Paclitaxel with modest 
improvement of dysphagia symptoms and reduction of 10-15% of the 
target lesions. The clinical course was characterized by loco-regional 
progression of the disease with exitus in 10 months after diagnosis. 
Survival and quality of life after surgical therapy and chemotherapy 
were like that of patients undergoing only chemotherapy. Due to the 
extreme rarity of the neoplasia, 60 cases described in Literature, no 
exclusive guidelines are reported for PSCCT. More extensive case 
studies are needed to evaluate the effects of total thyroidectomy with 
intent R0/R1 on improving survival and quality of life of patients with 
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cal course like anaplastic carcinoma (3,4). Only 60 cases 
have been reported in the literature (5). The average age 
of patients at the time of diagnosis is 63 years; women are 
affected almost twice as much as men. The clinical onset 
is characterized by the presence of a mass in the neck from 
extra-thyroid spread of the neoplasm; lymph node involve-
ment is reported in 48.3% of patients. Doubts persist about 
the tissue of origin of PSCCT for not being present in the 
thyroid squamous epithelium. Several hypotheses have been 
proposed on the origin of the PSCCT: a) from the squamous 
cells of the thyroglossal duct and from the branchial arch 
residues; b) from squamous metaplasia during chronic 
thyroiditis, follicular adenoma, follicular epithelium, papil-
lary carcinoma (4-6). Immunohistochemistry is necessary 
for the differential diagnosis between primary squamous 
cell and metastatic squamous cell carcinoma of the thyroid 
(7,8). Positivity for thyroglobulin and PAX8 suggests a 
thyroid origin (7,8). However, multilayer total body CT 
is essential for the differential diagnosis of primary and 
secondary thyroid neoplasia. Total thyroidectomy seems to 
be associated with improved survival rate of patients with 
PSCCT characterized by radiochemical resistance (1,9). The 
authors report the case of a 58-year-old man undergoing 
total thyroidectomy for multinodular goiter and bilateral 
latero-cervical lymphadenopathy.
Clinical Case
58-year-old patient with no significant family, physio-
logical and remote medical history for thyroid disease. For 
about 2 months, presence of worsening bilateral latero-
cervical lymph node enlargement with deformation of the 
neck profile. On physical examination the lymph node 
formations which were not spontaneously painful and not 
painful to palpation, had a hard consistency and a diameter 
between 16 and 31 mm. The patient did not report any signs 
of compression or laryngeal, tracheal, and esophageal infil-
tration. Thyroid hormones (TSH, FT3, FT4), thyroglobulin 
(TG) and thyroid anti-peroxidase (anti-TPO) antibodies fall 
into the normal range. The diagnosis of medullary carcino-
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ma was excluded because calcitonin was within the normal 
range (<1.0 pg / ml, see N. 0.1-10). The echotomography 
(US) showed volumetric increase of the thyroid (right lobe 
diameter 42.8 mm, left lobe diameter 24mm, isthmus dia-
meter 13.3 mm). The parenchymal echostructure appeared 
diffusely inhomogeneous with multiple pseudo-nodular 
images confluent in the right lobe. In the left lobe there was 
presence of hypoechoic nodular formation (with a diameter 
of 28x17 mm) with peri and intra-nodular vascularization. 
In the right laterocervical region, there was evidence of vo-
luminous grossly roundish lymph node formations, which 
at the US showed loss of normal ecostructural features, 
disordered vascularization and a diameter between 16 -26 
mm. In the left laterocervical region there was evidence of 
lymph node formation (with a diameter of 31x14 mm), with 
a roundish appearance and disordered vascularization. The 
patient underwent total thyroidectomy. The peri-isthmic 
tissue was removed due to the presence of a small roun-
dish formation, that was due to lymph node metastasis at 
histological examination.    The organ appeared increased 
in volume, with the right lobe tenaciously adherent to the 
band-like muscles and to the perithyroidal soft tissues due 
to extra-glandular neoplastic diffusion phenomena. The 
surface of the gland presented an irregular appearance with 
presence, when cut, of multiple areas of greyish color with 
poorly defined margins. On histological examination, the 
parenchyma appeared as the site of diffused proliferation 
of medium and large epithelial cells arranged in nests and 
solid cords (Fig. 1). 
The nuclei appeared to be polymetric, often vesicular 
with evident and sometimes hyperchromatic nucleoli, large 
eosinophilic cytoplasm and occasional evidence of tight jun-
ctions between the cells. There was presence of desmosomes 
or spines, characteristic of the squamous cellular nature of 
the neoplasm (Fig. 2). 
There were numerous atypical mitoses, some apoptotic 
bodies, foci of necrosis and multiple foci of endovascular 
invasion. The neoplasm extended to the perithyroidal soft 
tissues. In the peri-isthmic cells there was a metastatic lym-
ph node with a parenchyma largely replaced by neoplastic 
proliferation. The immunohistochemical study showed 
positivity for CKAE1/AE3, CK5/6, CK19, p63, p53, TTF1 
(weak and widespread), thyroglobulin (occasionally), and 
negativity for vimentin, galectin 3, CD56, chromogranin 
A, synaptophysin, NSE, HBME1, CD5 and calcitonin. The 
immunophenotypic profile of the proliferation is reported 
in the IHC panel (Fig. 3).
 The proliferation index, evaluated by Ki 67, was equal 
to 80%. The histopathological picture gave us evidence on 
the diagnosis of carcinoma that was poorly differentiated 
with multiple foci spread throughout the thyroid, aspects of 
squamous differentiation and extensive intravascular diffu-
sion and perithyroidal soft tissues. The neoplasm was present 
at the margins of surgical resection. Postoperative staging 
included: clinical examination, US, multi-layer total-body 
CT and segmental bone scintigraphy (after total-body and 
99mTc-MDP radiopharmaceuticals administration), with 
740 MBq administered activity. The scintigraphic images 
did not document the presence of areas of altered setting 
of the osteotropic tracer of secondary skeletal significance. 
At the multilayer CT the pulmonary parenchyma appeared 
symmetrical and normo-ventilated bilaterally with absence 
of focal alterations. No lesions were seen in the trachea and 
the large arterial and venous vessels. Presence of gross lym-
ph node packs in pre-tracheal, retrosternal, hilar, bronchial 
bifurcation and at the aorto-pulmonary window. The lymph 
nodes were increased in volume and presented central areas 
of necrotic-colliquative degeneration. The pleural sinuses 
were free of effusion. Absence of focal hepatic changes. 
Pancreas, spleen, adrenal glands and kidneys without signi-
ficant alterations. Not increased abdominal lymph nodes. 
No changes in brain density were demonstrated. The ven-
tricular system appeared in axis and of normal amplitude. 
At the oncological examination, performed 8 weeks after 
the surgical treatment, bilateral lymph node packs of 5 cm 
diameter were appreciated in the bilateral latero-cervical 
region and in the supra-clavicular fossa.  The patient, per-
formance status 2, reported pain of this objectivity (VAS 
score=5), which resulted in painkiller therapy with major 
opioids (oxycodone 20 mg twice daily). The radiothera-
peutic option was excluded due to the massive extension 
of the recovery of the illness, and the poor performance 
status. The immunotherapeutic option was not available as 
Fig. 1. H/E  x 100 section from the thyroid gland showing infiltrative 
squamous cell carcinoma of thyroid.
Fig. 2. Desmosomes are evident between neoplastic cells demon-
strating a squamous differentiation (H/E x 600)
e233Thyroid primary squamous cell carcinoma
standard treatment in Italy, repayable by AIFA. The patient 
underwent first-line chemotherapy treatment according to 
the scheme which consisted of Carboplatin AUC 4 and Pa-
clitaxel 175 mg / m² every 21 days. The 4 treatment cycles, 
except for alopecia, were well tolerated without any G3-G4 
grade toxicity according to CTCAE V.4.2. At the end of the 
chemotherapy treatment, the patient reported improvement 
of the painful symptomatology, which allowed the reduction 
of the daily dosage of opioids (oxycodone 5 mg twice daily). 
At the multilayer CT re-evaluation, instrumental stability of 
the disease according to the Recist criteria was highlighted, 
with a tendency to reduce all target lesions by 10-15%. 
Based on the good clinical and instrumental response and 
the excellent tolerability to chemotherapy treatment, it was 
decided to subject the patient to a further 3 cycles with 
Carboplatin and Paclitaxel. The subsequent clinical course 
was characterized by rapid loco-regional progression of 
the disease with infiltration of the internal carotid artery by 
bilateral lateral-cervical lymph node metastases, and exitus 
in 10 months after diagnosis. 
Discussion
Primary squamous cell carcinoma of the thyroid 
(PSCCT) is a rare neoplasm, difficult to diagnose and with 
an unfavorable prognosis (1,2). It is often poorly differen-
tiated, that is why the immunophenotypic study is essential 
for a correct diagnosis. As reported in the literature, and also 
in this case, the immunohistochemical investigation and 
multilayer CT has proved to be an indispensable method 
for the differential diagnosis between PSCCT and extra-
thyroid squamous cell carcinoma with secondary glandular 
localization (SCCT), which has a more frequent response 
and a better prognosis due to the increased sensitivity to 
radio-chemotherapeutic treatment (4). The morphological 
appearance of the proliferation of medium and large epi-
thelial cells organized in solid nests and cords, the absence 
of papillary or follicular structures, the negativity of the 
immunophenotypic markers of galectin 3 and HBME1 
allowed to exclude the diagnosis of papillary and follicular 
carcinomas. The normal value of serum calcitonin and the 
negativity of anti-calcitonin antibody in neoplastic tissue 
have excluded the diagnosis of medullary carcinoma. The 
negativity to the CD56, chromogranin A, synaptophysin and 
NSE markers excluded the neuroendocrine nature of the ne-
oplasm. The morphological aspect of the lesion, which was 
poorly differentiated but never frankly anaplastic, and the 
immunohistochemical profile characterized by the p63 and 
cytokeratins 5/6 positivity, allowed the correct differential 
diagnosis between the PSCCT and the anaplastic thyroid 
carcinoma of which it shares the clinical aggressiveness, 
Fig. 3. Immunoistochemistry results: Tumor shows diffuse positivity for CKAE1/AE3 (A), CK5/6 (B) e p63 (C), scattered thyroglobulin- positive 
cells (D) and TTF-1-positive cells (E) and negativity for calcitonin (F).
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treatment and inauspicious outcome. Squamous cell car-
cinomas of the thyroid are often associated with the most 
common papillary carcinoma, which sometimes presents 
aspects of squamous differentiation. 
In our case, despite the extensive sampling of the organ, 
there were no signs of chronic thyroiditis and no presence of 
other types of thyroid neoplasia. The finding excluded the 
possible origin of this tumor from inflammatory or neopla-
stic lesions already present in the thyroid. The multilayer 
CT allowed to exclude the presence of primary epithelial 
neoplasms of the lung, larynx and of the nasopharynx, which 
can give metastases to the thyroid. Therefore, the total body 
multi-layer CT should be performed in all patients because 
it is an indispensable method to confirm the thyroid, pul-
monary or extra-pulmonary origin of the squamous cell 
neoplastic lesions. In addition, our case also presented an 
occasional positivity for anti-thyroglobulin antibody in neo-
plastic cells, this fact supports the hypothesis of a primitive 
thyroid neoplasia.
As reported in the literature, in this clinical case a wide-
spread and early lymph node involvement was demonstrated 
at the onset of the disease. The US of bilateral latero-cervical 
regions, and supra-clavicular areas, revealed enlarged roun-
dish lymph node formations organized in packets and with 
altered echostructure. CT showed widespread involvement of 
mediastinal lymph nodes. The pre-tracheal, retrosternal, ca-
renal, intrabronchial, hilar, and aortopulmonary lymph nodes 
were markedly increased in size and showed central areas of 
necrotic-colliquative degeneration. The lymph nodes of the 
upper and lower abdominal stations showed no appreciable 
volumetric changes and structural changes. Indication was 
given to total thyroidectomy which, in the most favorable 
cases, seems to be associated with improved survival (1). The 
intraoperative finding of extensive infiltrative phenomena 
of the perithyroidal tissues with involvement of surgical 
resection margins, the high cell proliferation index and 
intravascular diffusion, influenced for a rapidly unfavorable 
prognosis lesion, with a clinical course superimposable to 
anaplastic carcinoma. Due to the high local invasiveness, 
the complete surgical resection of the neoplasm was not 
possible. The clinical controls, US and CT performed in 8 
weeks distance from the total thyroidectomy with emptying 
of the central compartment, showed a significant increase 
in the volume of the lymph nodes (diameter> 5 cm) in the 
bilateral latero-cervical area, which were of increased con-
sistency, organized in big chains, due to cervico-thoracic 
compression dysphagia.  
The first-line chemotherapeutic treatment with Carbo-
platin and Paclitaxel, well tolerated by the patient, resulted 
in an improvement of the painful symptomatology and 
instrumental stability of the disease. 
The patient’s exitus occurred 10 months after diagnosis, 
confirming the high malignancy of the PSCCT. Surgical the-
rapy and chemotherapeutic treatment have not been proven 
to ensure acceptable local control of the disease. Survival 
and quality of life were comparable to that of patients treated 
only with chemotherapy (1,2,9,10). 
Due to the extreme rarity of the neoplasia, 60 cases 
described in Literature, no exclusive guidelines are repor-
ted for the PSCCT. There is no unanimous agreement on 
risks, morbidity and quality of life after surgical treatment 
for the PSCCT. More extensive case studies are needed to 
evaluate the impact on survival from surgical therapy with 
intent R0 / R1.
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